DRAFT ZOONOTIC DISEASE ERADICATION AND CONTROL (AMENDMENT) (EU EXIT) REGULATIONS 2019 Debate
Full Debate: Read Full DebateLuke Pollard
Main Page: Luke Pollard (Labour (Co-op) - Plymouth Sutton and Devonport)Department Debates - View all Luke Pollard's debates with the HM Treasury
(5 years, 5 months ago)
General CommitteesI have a brief question. I wanted to pick the Minister up on something he said in his opening speech about trade and the list of countries where, effectively, we authorise trade.
The regulations refer to Finland and Norway. Can the Minister expand on the list of countries, and explain whether the United States is part of the wider list he mentioned? He will be aware in particular of the greater prevalence of salmonella in the US, where 1.2 million people are affected each year and there are 23,000 hospitalisations. The US Centres for Disease Control and Prevention estimate that there are roughly 380 deaths because of salmonella each year in the US. In comparison there are on average about 8,500 cases a year in the UK. In a report that it published last year, Sustain raised concerns about food safety fears in US-UK trade deals, and their potential additional cost to the NHS. I should be grateful if the Minister would tell us whether any representations have been made.
I note the document published by the US trade ambassador about US trade negotiation principles. There is something in it that could affect the salmonella effect, in relation to US agriculture and their objective to eliminate
“practices that unfairly decrease U.S. market access opportunities or distort agricultural markets to the detriment of the United States, including non-tariff barriers”.
Given the considerably greater prevalence of salmonella in the agriculture sectors of the US, maintaining high food safety standards will be important after we leave the European Union and I should be grateful if the Minister would explain whether the US is on the country list he mentioned. Also, should there be trade deals with any countries with a salmonella issue, what scrutiny arrangements would be available in respect of the powers and obligations in the statutory instrument?